Weekly podcasts from Science Magazine, the world's leading journal of original scientific research,
First up on the podcast, U.S. aid helped two African countries rein in HIV. Then came President Dona
First up on the podcast, Contributing Correspondent Andrew Curry joins host Sarah Crespi to discuss
First up on the podcast, the Vera C. Rubin Observatory is just coming online, and once fully operati
First up on the podcast, Staff Writer Erik Stokstad talks with host Sarah Crespi about how scientist
First up on the podcast, we hear from Staff Writer Paul Voosen about the tricky problem of regional
First up on the podcast, Online News Editor Michael Greshko joins host Sarah Crespi to talk about st
First up on the podcast, freelance journalist Zack Savitsky joins host Sarah Crespi to talk about th
First up on the podcast, freelance journalist Jonathan Moens talks with host Sarah Crespi about a fo
First up on the podcast, producer Meagan Cantwell worked with the Science News team to review how th
First up on the podcast, Contributing Correspondent Andrew Curry talks with host Sarah Crespi about
First up on the podcast, bringing Gregor Mendel’s peas into the 21st century. Back in the 19th centu
First up on the podcast, Online News Editor David Grimm joins host Sarah Crespi to talk about how an
(Main Text)First up on the podcast, ScienceInsider Editor Jocelyn Kaiser joins host Sarah Crespi to
Geoengineering experiments face an uphill battle, and a way to combat the pregnancy complication hyp
First up this week, urban wildfires raged in Los Angeles in January. Contributing Correspondent Warr
First up this week, Newsletter Editor Christie Wilcox joins host Sarah Crespi to discuss stories fro
First up this week, science policy editor Jocelyn Kaiser joins host Sarah Crespi to discuss the late
First up this week, International News Editor David Malakoff joins host Sarah Crespi to discuss the
First up this week, Kata Karáth, a freelance journalist based in Ecuador, talks with host Sarah Cres
First up this week, researchers face impossible decisions as U.S. aid freeze halts clinical trials.